J Korean Med Assoc.  2003 Sep;46(9):815-823. 10.5124/jkma.2003.46.9.815.

Depressive Disorders in Children and Adolescents

• Ahn DH

• KMID: 2183122
• DOI: http://doi.org/10.5124/jkma.2003.46.9.815

Abstract

Child and adolescent major depressive disorder(MDD) and dysthymic disorder(DD) are common, chronic, familial, and recurrent conditions that usually persist into adulthood. These are not only accompanied by several comorbid disorders(i.e., anxiety disorders and conduct disorders), but also increased risk for suicide, substance abuse, delinquency, school failure, and behavioral problems. Additionally, children and adolescents with MDD and/or DD frequently have poor family, academic, and interpersonal functioning. Thus the importance of early identification, comprehensive diagnosis, and proper treatment of the disorders has been emphasized. The treatment of MDD may be divided into three phases : acute, maintenance, and continuation. In acute phase, psychosocial treatment may be the first-line option for most depressive youth ; however, pharmacotherapy should be considered for a high-risk group. Currently, SSRIs antidepressants are efficacious for the treatment of adolescents with MDD, and have a relatively less side effects. Most clinicians favor the SSRIs as first-line medications for the depressive youth. Because of the high rate of relapse and recurrence of depression, all patients need continuation treatment for at least 6 to 12 months and some patients may require maintenance therapy from 1 year to life-long. All clinicians who are involved with the treatment of depressive youth should foster the effective therapeutic alliance and educate the patient and family about the disorder and its treatment to maintain proper treatment. Finally further research is needed on the several facets of child and adolescent depressive disorders.

Keyword

Child; Adolescent; Depression

MeSH Terms

Adolescent*
Antidepressive Agents
Anxiety Disorders
Child*
Depression
Depressive Disorder*
Diagnosis
Drug Therapy
Humans
Recurrence
Substance-Related Disorders
Suicide
Antidepressive Agents

Reference

2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder. 1994. 4th ed. Washington DC: American Psychiatric Association.

3. American Academy of Child and Adolescents Psychiatry. Practice Parameter for the Assessment and Treatment of children and Adolescents With Depressive Disorder. J Am Acad Child Adolesc Psychiatry. 1998. 37:10 Suppl. 63S–83S.

7. Birmaher B, Brent D. Martin A, Cahill L, editors. Depressive disorders. Pediatric Psychopharmacology : Principles and Practice. 2003. New York: Oxford University Press;466–483.

8. Hammen C, Rudolph KD. Mash EJ, Barkley RA, editors. Childhood mood disorders. Child Psychopathology. 2003. 2nd ed. New York: Guilford Press;233–278.

11. American Psychiatric Association. Practice for the treatment of patients with major depressive disorder [revision]. Am J Psychiatry. 2000. 157:4 Suppl. 1–45.